Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate Student Research Awards (USRA)

University of Toronto

$6,000.00

Investigating the Role of Telomere shortening in oligodendrogenesis

FY 2025-26

Summary
Telomere shortening, a hallmark of aging, has been correlated with multiple sclerosis (MS) severity and progression, however the mechanisms remain unclear. It has been proposed that the age-related decline in remyelination contributes to the progressive phase of MS. Remyelination is a regenerative response to myelin loss and protects axons from irreversible degeneration. For efficient remyelination, oligodendrocyte precursor cells (OPCs) must differentiate into myelin-producing oligodendrocytes. Recent evidence suggests that, in the aging central nervous system (CNS), OPCs lose their ability to differentiate into oligodendrocytes. The underlying causes of this impaired oligodendrogenesis in the aging CNS remain poorly understood. This proposal aims to investigate whether telomere shortening in OPCs impairs their differentiation. To test this, we will inhibit telomerase reverse transcriptase (TERT) in OPCs to accelerate telomere shortening and assess its effects on cellular senescence and OPC differentiation into oligodendrocytes. We will treat mouse primary OPC cultures with the TERT inhibitor BIBR1532 (60 µM) for one week in proliferation media to significantly reduce telomere length. After the proliferation phase, the media will be switched to differentiation media, allowing the cells to mature into oligodendrocytes. TERT deletion and telomere length will be validated using PCR, and telomerase activity will be confirmed with the Telomerase Repeat Amplification Protocol (TRAP) assay. To evaluate the effects of TERT deficiency, we will analyze aging markers including p21, p16, and SA-ß-galactosidase. Additionally, OPC differentiation into mature myelin-producing (MBP+) oligodendrocytes will be evaluated using immunofluorescent staining and confocal microscopy.
Program
Undergraduate Student Research Awards (USRA)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530998
Name
Bello-Osagie Joy Oghogho
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Role of Telomere shortening in oligodendrogenesis
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$6,000
Cihrequipment2
$0
Programname2
Undergraduate Student Research Awards (USRA)
Keyworddelim
Aging; Aging Markers; Central Nervous System; Multiple Sclerosis; Progression; Remyelination; Severity; Telomere Shortening
Abstract
Telomere shortening, a hallmark of aging, has been correlated with multiple sclerosis (MS) severity and progression, however the mechanisms remain unclear. It has been proposed that the age-related decline in remyelination contributes to the progressive phase of MS. Remyelination is a regenerative response to myelin loss and protects axons from irreversible degeneration. For efficient remyelination, oligodendrocyte precursor cells (OPCs) must differentiate into myelin-producing oligodendrocytes. Recent evidence suggests that, in the aging central nervous system (CNS), OPCs lose their ability to differentiate into oligodendrocytes. The underlying causes of this impaired oligodendrogenesis in the aging CNS remain poorly understood. This proposal aims to investigate whether telomere shortening in OPCs impairs their differentiation. To test this, we will inhibit telomerase reverse transcriptase (TERT) in OPCs to accelerate telomere shortening and assess its effects on cellular senescence and OPC differentiation into oligodendrocytes. We will treat mouse primary OPC cultures with the TERT inhibitor BIBR1532 (60 µM) for one week in proliferation media to significantly reduce telomere length. After the proliferation phase, the media will be switched to differentiation media, allowing the cells to mature into oligodendrocytes. TERT deletion and telomere length will be validated using PCR, and telomerase activity will be confirmed with the Telomerase Repeat Amplification Protocol (TRAP) assay. To evaluate the effects of TERT deficiency, we will analyze aging markers including p21, p16, and SA-ß-galactosidase. Additionally, OPC differentiation into mature myelin-producing (MBP+) oligodendrocytes will be evaluated using immunofluorescent staining and confocal microscopy.
Competitiondate
202505
Approvedterm2
0 yr 4 mths
Pinamesdelim
Bello-Osagie, Joy Oghogho
Approvedterm
0 an 4 mois
Cihrcontribution2
~ $6,000~ $0~